Pharmacy Board reviews multiple assembly bills impacting pharmacist authority and public health

The California State Board of Pharmacy convened on June 11, 2025, to discuss several key legislative measures that could significantly impact pharmacy practices and public health in the state. Among the most notable topics was Assembly Bill 50, which aims to empower pharmacists to furnish over-the-counter hormonal contraception without the need for standardized procedures typically required for prescription medications. This bill has garnered support from the board, reflecting a commitment to improving access to reproductive health services.

Another important measure discussed was Assembly Bill 309, which would allow pharmacists to provide hypodermic needles and syringes for personal use. The board expressed its intention to support this legislation, recognizing its potential to enhance public health by reducing the spread of diseases associated with needle sharing.

The committee also reviewed Assembly Bill 447, which would permit emergency room prescribers to dispense unused portions of dangerous drugs to patients upon discharge. While the board acknowledged the potential benefits of this measure, concerns were raised regarding labeling and documentation practices, emphasizing the need for clear guidelines to ensure patient safety.

In addition, Assembly Bill 529 was highlighted for its proposal to extend the board's authority to waive certain pharmacy law provisions for up to 120 days following a declared emergency. This flexibility could be crucial in responding to future public health crises.

The board also discussed Assembly Bill 669, which seeks to ensure coverage for substance use disorder treatment, including prohibiting prior authorization for FDA-approved medications deemed necessary by healthcare providers. This measure aligns with ongoing efforts to address the opioid crisis and improve access to addiction treatment.

Lastly, Assembly Bill 957 aims to prohibit pharmacies from selling cigarettes and tobacco products, reinforcing the board's commitment to public health and wellness.

As these legislative measures progress, the board's support positions reflect a proactive approach to enhancing pharmacy practices and addressing critical health issues in California. The next steps will involve continued monitoring of these bills as they move through the legislative process, with the board poised to advocate for measures that prioritize community health and safety.